Glen Harbor Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $339K | Sell |
9,240
-84
| -0.9% | -$3.08K | 0.01% | 842 |
|
|
2019
Q2 | $434K | Sell |
9,324
-2,436
| -21% | -$113K | 0.01% | 748 |
|
|
2019
Q1 | $472K | Buy |
11,760
+364
| +3% | +$14.6K | 0.01% | 698 |
|
|
2018
Q4 | $524K | Sell |
11,396
-2,324
| -17% | -$107K | 0.01% | 599 |
|
|
2018
Q3 | $609K | Buy |
13,720
+11,900
| +654% | +$528K | 0.01% | 639 |
|
|
2018
Q2 | $71K | Sell |
1,820
-15,848
| -90% | -$618K | ﹤0.01% | 1182 |
|
|
2018
Q1 | $1.28M | Buy |
17,668
+13,384
| +312% | +$968K | 0.03% | 364 |
|
|
2017
Q4 | $282K | Sell |
4,284
-3,108
| -42% | -$205K | 0.01% | 857 |
|
|
2017
Q3 | $371K | Sell |
7,392
-896
| -11% | -$45K | 0.01% | 690 |
|
|
2017
Q2 | $384K | Sell |
8,288
-2,800
| -25% | -$130K | 0.01% | 667 |
|
|
2017
Q1 | $391K | Hold |
11,088
| – | – | 0.01% | 617 |
|
|
2016
Q4 | $139K | Buy |
+11,088
| New | +$139K | ﹤0.01% | 800 |
|